CD8A and melanoma: Loss-of-function studies validate this mechanism: L. reuteri ΔAAT (a Trp catabolism-deficient strain) fails to produce I3A or suppress melanoma growth, while CD8+ T cell-specific AhR knockout completely abrogates I3A-driven tumor suppression (113).